Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 4
2010 2
2011 1
2013 4
2014 2
2015 1
2016 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Genet Med. 2013 Jul;15(7):517-27. doi: 10.1038/gim.2012.184. Epub 2013 Feb 21. Genet Med. 2013. PMID: 23429431 Free article.
Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Genet Med. 2011 Jan;13(1):67-76. doi: 10.1097/GIM.0b013e3181fbe46f. Genet Med. 2011. PMID: 21150787 Free article.
Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group*. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group*. Genet Med. 2016 Aug;18(8):770-9. doi: 10.1038/gim.2015.173. Epub 2015 Dec 17. Genet Med. 2016. PMID: 26681310 Free article.
Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Genet Med. 2007 Dec;9(12):819-25. doi: 10.1097/gim.0b013e31815bf9a3. Genet Med. 2007. PMID: 18091431 Free PMC article.
Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Genet Med. 2009 Jan;11(1):15-20. doi: 10.1097/GIM.0b013e31818efd9d. Genet Med. 2009. PMID: 19125128 Free PMC article.
The EGAPP initiative: lessons learned.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Genet Med. 2014 Mar;16(3):217-24. doi: 10.1038/gim.2013.110. Epub 2013 Aug 8. Genet Med. 2014. PMID: 23928914 Free article. Review.
Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Genet Med. 2009 Jan;11(1):35-41. doi: 10.1097/GIM.0b013e31818fa2ff. Genet Med. 2009. PMID: 19125126 Free PMC article.
Recommendations from the EGAPP Working Group: does genomic profiling to assess type 2 diabetes risk improve health outcomes?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group; Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group, et al. Genet Med. 2013 Aug;15(8):612-7. doi: 10.1038/gim.2013.9. Epub 2013 Mar 14. Genet Med. 2013. PMID: 23492873 Free article.
13 results